Welcome to the Division! Looking forward to working with each of you! @sumanthprabhu01 Karen Joynt Maddox DH Cooper Justin Vader Thomas M. Maddox MD Kristen Wong Raja Zaghlol Stephen Philip

Statins and Left Ventricular Ejection Fraction Following Doxorubicin Treatment | NEJM Evidence evidence.nejm.org/doi/full/10.10… Prospective statin administration did not affect LVEF declines 2 years after doxorubicin. AG40 - Onkologische Kardiologie International Cardio-Oncology Society

Checkout our editorial on a great article investigating the role of biomarkers and quantitative PYP uptake on the prognosis of ATTR cardiac amyloidosis in the modern Tafamidis era, hot off press in Journal of Cardiac Failure. sciencedirect.com/science/articl…

Congratulations Johana R. Fajardo DNP for presenting work from our database of patients on ambulatory inotropic therapy, and taking it a step further with cardiac amyloidosis.

Proud of our team for such a great review article on the use of cardiac #biomarkers in the world of #cardioonc

How awesome! Two of my ⁦WashU Cardiology Fellowship⁩ presenting posters ⁦American College of Cardiology⁩ #ACC23/WCC side by side! Makes a PD proud. ⁦WashU Medicine Cardiovascular Division⁩ ⁦Raja Zaghlol⁩ ⁦@notquiteSteven⁩

WashU Cardiology Fellowship

Here with my WashU Medicine Cardiovascular Division and WashU Cardiology Fellowship family. American College of Cardiology #acc23 #smitholiversociety Barnes-Jewish

onlinejcf.com/article/S1071-… A great scientific statement in Journal of Cardiac Failure for current diagnostic, prognostic, and therapeutic roles of natriuretic peptides in various HF scenarios. Many great learning pearls and figures! Highly recommended to read.

(1/10) Today the long-awaited full results from the Phase 3 ATTRibute-CM trial were presented European Society of Cardiology #ESCCongress. We already knew the topline results from last month: Acoramidis made a (big) difference in outcomes! What more did we learn?🤔Let's dig deeper...

Having fun and learning at our first #HFSA meeting! Kristen Wong #HFSA2023 WashU Cardiology Fellowship

"📆 Dec 6th Journal Club: Exploring biomarkers in ICI Myocarditis diagnosis & prognosis. Join Drs. Raja Zaghlol, Alvarez-Cardona, Lenihan & Carver for a deep dive 🎙️. Details: tinyurl.com/56s2u2yz Radcliffe Cardiology #CardioOnc #MedTwitter"

Proud to be selected as a YIA finalist in the #GCOS2024 presenting our work investigating MACE in older adults receiving CART therapy. Special thanks to Joshua Mitchell for exceptional mentoring. International Cardio-Oncology Society

Check out our review of CV complications of radiation therapy. Grateful for the amazing team that helped put this together.

Now in publication and available on Amazon! Honored to author 2 chapters along with this amazing group of experts and mentors (Invasive Hemodynamics and Acute Decompensated HF). Congratulations to Jonathan D. Moreno and Benjamin Kopecky for leading such a great feat

One of the more dynamic fields in cancer tx is the evolution of radiation therapy--as well as cardiotoxicity Joshua Mitchell Carmen Bergom MD PhD Raja Zaghlol et al provide this excellent review of past, present and future avenues radiation CV toxicity cardiology.theclinics.com/article/S0733-… 13/ 🧵

Where to find WashU Cardiology at #ACC25 ! Here's where you can see Dr. Raja Zaghlol:

We won the National ACC FIT Jeopardy this year 🎉🎉 go team Missouri🎊🎊WashU Medicine Cardiovascular Division Shreyas Venkataraman Andy Kates

How do you win #FITJeopardy at #ACC25? Missouri’s team — Drs. Iqbal, Raja Zaghlol & Shreyas Venkataraman — pulled off the chapter’s 1st-ever national win! But it wasn’t just about right answers. It was about trust, balance & belief. 📖 ow.ly/qG4x50VK25e #MOACC #Cardiology

Check out our publication in #CardioOncology. Atrial fibrillation/flutter in stem cell transplant patients. Prevalence, association with outcomes, and impact on healthcare resource-utilization/readmissions. Joshua Mitchell Ahmed Teebi, MD MPH🗝️ rdcu.be/euXbx